We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
FATE icon
1
Fate Therapeutics
FATE
$249M
$249M $2.08 4.15%
ABEO icon
2
Abeona Therapeutics
ABEO
$249M
$249M $4.35 4.61%
CAMP icon
3
CAMP4 Therapeutics
CAMP
$249M
$249M $3.96 1.54%
ALEC icon
4
Alector
ALEC
$247M
$247M $2.21 1.34%
IFRX icon
5
InflaRx
IFRX
$245M
$245M $1.66 3.49%
EVMN icon
6
Evommune Inc
EVMN
$244M
$244M $6.73 1.17%
IMRX icon
7
Immuneering
IMRX
$243M
$243M $3.75 6.72%
OCGN icon
8
Ocugen
OCGN
$238M
$238M $0.7027 5.58%
VNDA icon
9
Vanda Pharmaceuticals
VNDA
$229M
$229M $3.79 6.42%
ELDN icon
10
Eledon Pharmaceuticals
ELDN
$225M
$225M $2.77 8.88%
SLGL icon
11
Sol-Gel Technologies
SLGL
$224M
$224M $68.35 0.45%
ACIU icon
12
AC Immune
ACIU
$221M
$221M $2.22 6.33%
KROS icon
13
Keros Therapeutics
KROS
$219M
$219M $11.04 2.82%
IKT icon
14
Inhibikase Therapeutics
IKT
$216M
$216M $1.55 7.19%
KRRO icon
15
Korro Bio
KRRO
$211M
$211M $14.31 0.77%
BBOT icon
16
BridgeBio Oncology
BBOT
$210M
$210M $2.62 2.96%
ARTV icon
17
Artiva Biotherapeutics
ARTV
$205M
$205M $4.19 0.95%
PALI icon
18
Palisade Bio
PALI
$202M
$202M $1.16 2.52%
RNAC icon
19
Cartesian Therapeutics
RNAC
$196M
$196M $6.49 3.85%
PRQR icon
20
ProQR Therapeutics
PRQR
$196M
$196M $1.39 3.47%
DTIL icon
21
Precision BioSciences
DTIL
$195M
$195M $7.06 5.11%
ACOG icon
22
Alpha Cognition
ACOG
$190M
$190M $8.74 4.9%
CGEN icon
23
Compugen
CGEN
$188M
$188M $1.98 2.94%
UPB icon
24
Upstream Bio Inc
UPB
$187M
$187M $3.41 4.28%
ZNTL icon
25
Zentalis Pharmaceuticals
ZNTL
$186M
$186M $1.96 1.51%
1
2 3 4 5

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 292 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $18.5B.

The largest by market cap are Fate Therapeutics (FATE) at $249M, Abeona Therapeutics (ABEO) at $249M and CAMP4 Therapeutics (CAMP) at $249M.

Among institutional investors, Eledon Pharmaceuticals (ELDN) drew the most net new fund positions in Q2 2026: 51 funds opened new positions, taking total fund holders up 40 (33%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.